Secondary CNS Lymphoma
Showing 1 - 25 of >10,000
Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)
Recruiting
- Secondary Central Nervous System Lymphoma
- Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
May 25, 2022
CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)
Recruiting
- Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- TEDD-R
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)
Recruiting
- CNS Lymphoma
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 10, 2022
CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Zanubrutinib, Lenalidomide, Zanubrutinib, Lenalidomide)
Recruiting
- Central Nervous System Lymphoma
- Rituximab, Lenalidomide, Zanubrutinib
- +2 more
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Jun 16, 2021
Diffuse Large B Cell Lymphoma, CNS Metastasis Trial in Herlev
Recruiting
- Diffuse Large B Cell Lymphoma
- Central Nervous System Metastasis
-
Herlev, Capital Region, DenmarkHerlev Hopital
Mar 21, 2022
CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)
Recruiting
- Central Nervous System Lymphoma
-
Chapel Hill, North Carolina
- +1 more
Mar 24, 2022
Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial
Suspended
- Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
- Obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
CNS Lymphoma, Non-Hodgkin Lymphoma Trial in Berlin
Recruiting
- Central Nervous System Lymphoma
- Non-Hodgkin Lymphoma
-
Berlin, GermanyCharité - Universitätsmedizin, Med. Klinik m. S. Hämatologie, On
Nov 8, 2021
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Not yet recruiting
- CNS Lymphoma
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 12, 2023
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
Active, not recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- DISEASE
- (no location specified)
May 4, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)
Not yet recruiting
- Non-hodgkin Lymphoma, B Cell
- ctDNA detection
-
Aarau, Switzerland
- +12 more
Oct 18, 2023
Primary CNS Lymphoma Trial in Paris (PET-MRI)
Not yet recruiting
- Primary Central Nervous System Lymphoma
-
Paris, FranceHôpital Pitié Salpêtrière
May 20, 2022
Primary CNS Lymphoma Trial in London (CD19CAR T-cells)
Recruiting
- Primary CNS Lymphoma
- CD19CAR T-cells
-
London, United KingdomUniversity College London Hospital
Jun 13, 2022
Relapsed or Refractory B-cell Lymphoma Trial (Relmacabtagene Autoleucel Injection)
Not yet recruiting
- Relapsed or Refractory B-cell Lymphoma
- Relmacabtagene Autoleucel Injection
- (no location specified)
Apr 13, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Saint Louis (Durvalumab, Acalabrutinib)
Recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Adult Patients With Diagnosed Relapsed or Refractory B-cell Lymphoma Who Have Completed Their First Treatment With Regiorense
Recruiting
- Adult Patients With Diagnosed Relapsed or Refractory B-cell Lymphoma Who Have Completed Their First Treatment With Regiorense Injection
- Relmacabtagene Autoleucel Injection
-
Shanghai, Shanghai, ChinaNO.197， Ruijin Er Road
Mar 28, 2023
Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))
Recruiting
- Primary CNS Lymphoma
- Hyperpolarized pyruvate (13C)
- Magnetic resonance imaging (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 22, 2022